CN Patent
CN114786724A — 防聚集剂以及使用该防聚集剂的药物组合物和医疗用设备
Assigned to Nipro Corp · Expires 2022-07-22 · 4y expired
What this patent protects
本发明的防聚集剂含有选自聚氧乙烯鲸蜡醚、聚氧乙烯脱水山梨糖醇脂肪酸酯和具有3000~13000的平均分子量的聚氧乙烯聚氧丙烯二醇(醚)的至少1种作为防聚集成分。根据本发明,可防止水难溶性药剂在内壁经硅油类处理的容器内因硅油类而发生聚集。
USPTO Abstract
本发明的防聚集剂含有选自聚氧乙烯鲸蜡醚、聚氧乙烯脱水山梨糖醇脂肪酸酯和具有3000~13000的平均分子量的聚氧乙烯聚氧丙烯二醇(醚)的至少1种作为防聚集成分。根据本发明,可防止水难溶性药剂在内壁经硅油类处理的容器内因硅油类而发生聚集。
Drugs covered by this patent
- Abilify (aripiprazole) · Generic (originally Otsuka/BMS)
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.